Morgan Stanley Investment Management (Morgan Stanley IM) has received approval from the China Securities Regulatory Commission (CSRC) to take a full controlling stake in its mainland China joint venture. Subject to business registration and other procedures required by Chinese regulators, Morgan Stanley IM will increase its stake in Morgan Stanley Huaxin Funds from 49% to 100%. Gokul Laroia, CEO of…
To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
In this article
Subscriber Only Content
This article is available on a corporate subscription with Asian Private Banker. Please login or subscribe to view this content.
Need help? Please see our FAQ Guide or email [email protected]